# RAltegravir Switch STudy: Effects on Endothelial Recovery

> **NCT01453933** · PHASE4 · UNKNOWN · sponsor: **UMC Utrecht** · enrollment: 24 (estimated)

## Conditions studied

- HIV Infection
- Endothelial Dysfunction

## Interventions

- **DRUG:** raltegravir

## Key facts

- **NCT ID:** NCT01453933
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2013-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01453933

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01453933, "RAltegravir Switch STudy: Effects on Endothelial Recovery". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01453933. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*